Skip to content
Clinical Trials – home

Dr. Tatyana Metalova Ambulatoria Za Individualna Praktika Za Spetsializirana Meditsinska EOOD

Verified siteinfo

Bulgaria Ulitsa Stara Planina 54, Floor 2 Room 23, 2900 Gotse Delchev, Bulgaria

  • 1 trial recruiting
  • Type 2 diabetes mellitus · Obesity · Overweight
  • Adult patients

About Specializations

Dr. Tatyana Metalova Ambulatoria Za Individualna Praktika Za Spetsializirana Meditsinska EOOD in Gotse Delchev, Bulgaria specialises in clinical trials of conditions such as Type 2 diabetes mellitus, Obesity, Overweight, and other specialisations. This site conducts important research.

Main research areas of the site

Nutritional and Metabolic Diseases

At Dr. Tatyana Metalova Ambulatoria Za Individualna Praktika Za Spetsializirana Meditsinska EOOD, researchers focus on metabolic health, specifically type 2 diabetes and overweight or obesity. The studies aim to evaluate innovative treatments that could improve blood‑sugar control and promote weight loss.

  • Testing a new therapy to improve glycemic control compared with existing options
  • Evaluating a novel agent for body‑weight reduction in individuals with excess weight and diabetes

The clinic in Gotse Delchev, Bulgaria has launched two investigator‑led studies, reflecting a commitment to advance care for patients across Europe.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ulitsa Stara Planina 54, Floor 2 Room 232900 Gotse DelchevBulgaria
Recruiting now
1 trial
Conditions studied
3
Partner status
Verified site

More sites in Gotse DelchevBulgaria

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Zenagamtide Compared with Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S

A study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.